Studies on the Chemical and Biological Properties of Coumestrol and Related Compounds (

Total Page:16

File Type:pdf, Size:1020Kb

Studies on the Chemical and Biological Properties of Coumestrol and Related Compounds ( 2 2 5 :; 1111/2.8 1111/2.5 :~ 1/1/1 .8 11111 . 1.0 1.0 32 W /////3.2 I~ 1111/ . ."'3 . 163 IE ~~~ .; 13.6 ~ I.\.ii ...c: I~ .0 :i I~ L. " I ~ u 1.1 ~t.:.u. 1.1 ~L.L.;. -- I 111111.8 111111.25 111111.4 111111.6 111111.25 111111.4 111111.6 MICROCOPY RESOLUTION TEST CHART MICROCOPY RESOLUTION TEST CHART NATIONAL BUREAU Of STANDARDS·1963·A NATIONAL BUREAU Of STANDARDS·1963·A Studies on the Chemical and Biological Properties of Coumestrol and Related Compounds ( Technical Bulletin No. 1408 Agricultural Resear~h Service UNITED STATES DEPARTMENT OF AGRICULTURE !/ Contents Page Page". Introduction ___ ___ ___ ___ __ __ ___ _ 1 Synthesis of coumestans-con. Analytical prol;edures _________ ,,_ 3 Synthesis from previously Biological procedures _. ________ 6 formed. cO'lrnestans __ _ __ __ __ 32 Chromatographic procedures _ __ 7 Physical properties of coumestans Qualitative procedure 8 Ultraviolet· absorption spectral Quantitative procedure _ _ _ _ _ _ 9 measurements ___ ___ __ __ __ __ 32 Other chromatographic pro- Proton magnetic resonance cedures __________________ 10 spectral measurements 35 Isolation _________ . _ • ___ ___ __ __ _ 14 Mass spectral measurements _ __ 37 Isolation of cournestrol from Chromatography - - - -- -- - _ 41 Ladino clover ______________ 15 Coumestrol in plants ____________ 43 Large-srllle processing of al- Variations as affected by cut­ falfa 'for coumestrol __ __ _ __ _ 1e tings and sta~'E!s of growth __ 43 Isolation of compoundu closely Variations as affected by loca­ related to coumestral _. 17 tion and climatic conditions _ _ 46 Characterization of coumestans __ 18 Variations as affected by varietal Coumestrol _ _ _ __ .. ___ . .. 20 and genetic differences ___ .._ 47 Trifoliol _ .• _ _ .• _ _ _ 20 Variations as related to disease_ 48 Medicagol ______ • ___ ..24 Mechanism of biosynthesis 53 4'-Q..methylcoumestrol __ . _ _ _ _ :1:4 Utilization of coumestrol by the 3'-Methoxycoumestrol __ . __ . ___ 24 animal ___ , , __________ . __ _ _ 55 Lucernol __ . _______________ 25 Metabolism __________ . _____ . __ 58 Sativol .. ___________ .________ 25 Estrogenic potency _ __ ___ ___ _ _ _ 59 11, 12-Dimethoxy-7-hydroxy- Antifertility effects -.--------- 63 coumestan -___ - - - . __ . __ - - . 26 Hyperestrogenic syndrome -.. 65 4',7-Dihydroxyflavone _______ - _ _ 26 Hypoestrogenic syndrome . - - - 69 3',4',7-Trihydroxyflavone _ _ __ __ _ 26 Antigonadotropic factors 72 Synthesis of coumestans _ _ _ ___ _ __ 27 Effects on rate of growth ______ 73 Cyclization of 4-hydroxy-3- Other biological effects _ _ _ __ 77 phenylcoumarin derivath,es 27 Correlation of structure and Oxidation of flavylium salts ____ 27 activity - - __ _ __ - - _ -- . ___ ----- 78 Condensation of catechol with Patents -._.____________________ 81 substituted 4-hydroxycou- Summary __ - ______ - ___ . _- ----- 82 marins •. ____ . _ . ____ . _. ___ . _ 30 Literature cited _ _ _ __ _ __ __ ___ __ _ _ 83 Trade names and the names of commercial companies are used in this publication solely to provide specific information. Mention of a trade name or manufacturer does not constitute a guarantee or warranty of the product by the U.S. Department of Agriculture or an endorsement by the Depart­ ment over other products not mentioned. Washington, D.C. Issued November 1969 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, D.C. 20402-Price 60 cents Studies on the Chemical and Biological Properties of Coumestrol and Related Compounds By E. ~. .BICKOFF, R. R. SPENCER, S. C. WITT, and B. E. KNUCKLES, chemists, Western 'Utilization Researrk and Development Division, Agricultu-ral Research Service . Introduction Natural estrogens in plants the Western Utilization Research have assumed. considerable im­ and Development Division portance since their connection (WURDD) as well as reports with infertility in grazing sheep from Cheng and co-workers at was demonstrated in 1946 by Iowa State (66, 67), Engle and Bennetts and co-workers (19)1 co-workers at Ohio State (98), and in 1948 by Curnow and co­ and Pieterse and Andrews at workers (83). These reports were Purdue (197) definitely estab­ followed in 1951 by the isolation lished that both alfalfa and La­ from subterranean clover of the dino clover frequently display sig­ isoflavone, genistein (56), which nificant estrogenic activity. In was shown to be estrogenically 1955, work was begun at active in mice (49, 82). Sutse­ WURDD on the occurrence, bio­ quently, the estrogenically active logical properties, and isolation isoflavones, formononetin, bio­ of the Ladino clover estrogen(s). chanin A, daidzein, and praten­ Surprisingly, the major com­ sein, were found in both subter­ pound, which was named coumes­ ranean and red clovers (39, 68, troT (30), was not an isoflavone 100, 221). At first genistein was as were all previously reported believed to be the factor that in­ forage estrogens. Instead, it terfered with the breeding of turned out to be a benzofurocou­ sheep (83). However, more re­ marin derivative belonging to an cent work suggests that formo­ entirely new class of compounds, nonetin may be more important which were later named coumes­ (84,182,184). tans (85). These compounds have Until 1953, alfalfa and Ladino subsequently been shown to be clover were considered to be biogenetically related to the iso­ among the nonestrogenic forages flavones (118). Coumestrol has a (54). However, experiments in close structural relationship not only to the isoflavones, but also 1 Italic nurnhers in parentheses refer to Literature Cited, p. 83. to the natural estrogen, estradiol, 1 \) 2 TECHNICAL ntJLLIllTIN 140S~ U.S. DEPT.OJl' .AGRICULTURE ,,:.- HO o Genistein Estradiol OH OH Coumestrol Diethylstilbestrol FIGURE I.-Structural formulas of genistein, estradiol, coumestrol, and diethylstilbestrol (.l1.l1). and the synthetic estrogen, di­ 222), white (105, 167), bur ethylstilbestrol (fig. 1). In fact. (167), subterranean (18, 167, Whalley (48) proposed that the 183, 184), and strawberry U8, estrogenic activity of coumestrol 105,167), as well as meadow flora can be attributed to its stilbene­ (179), Chinese milk vetch (217), like structure, which is analo­ soybeans (217), soybean sprouts gous to that of diethylstilbestrol. (217), pea silage,2 and commerc­ Studies established that cou­ ial samples of frozen peas and mestrol was the dominant estro­ beans (2). Studies on the varia­ gen of alfalfa (39, 122), Ladino tion in coumestrol content of al­ clover (39, 122), and the annual falfa and Ladino clover, as related medics (18, 104, 183). Although to environmental factors (36, 37, the isoflavones account for most 127), indicated that coumestrol of the estrogenic activity of red content was greatly affected by and subterraneiin clovers, their disease (43, 161,.) and insect in­ contribution to the estrogenicity festation (163). of alfalfa and Ladino clover is small (122). Subsequently, cou­ 2 Personal communication from J. H. mestrol was found in a wide Adler, animal physiologist, Hadassah varie'ty of clovers, e.g., red (167, Medical School, Israel, 1967. CHEMICAL AND BIOLOGICAL PROPERTIES OF COUrdESTROL 3 The discovery of coumestrol isolated from other plants. The stimulated a number of studies first compound of this basic related to its physiological effects structure was wedelolactone, on animals. Coumestrol has been which Govindachari and co­ shown to be considerably more workers (111,112) isolated from potent estrogenically for both Wedelia calendulacea in 1956. mice (39) and shE!ep (57) than Other naturally occurring cou­ has genistein. Reproductive prob­ mestans are erosnin isolated lems attributed to alfalfa and from Pachyrrhizus erosus (88), Ladino clover, such as those re­ psoralidin from PsoraZea coryli­ ported by Engle and co-workers folia (65, 86, 141), and norwede­ (98), Wright (224), and Adler lolactone from Eclipta alba and Trainin (6, 7, 8), can be ex­ (148). The structural formulas plained by the presence C)f cou­ of these naturally occurring cou­ mestrol. Estrogenically active al­ mestans are given in figure 2. falfa was shown to beneficially Coumestans are also structuraHy affect the rate of growth of cattle similar to the naturally occurring (176) and sheep (103, 194). Al­ isoflavonoids inermin (77), trifo­ though later results suggested lirhizin (59), pisatin (81, 196), that coumestroI was not the caus­ pterocarpin (60, 64, 198), and ative agent, coumestrol did im­ homopterocarpin (64, 171) (fig. prove the quality of the meat ob­ 3). This similarity in structure tained from sheep (131). was further demonstrated by In addition to coumestrol, Bowyer and co-workers (.53), seven other coumestans have who converted homopterocarpin been isolated from alfalfa (Med'i­ into coumeR+;rol dimethylether. cago sativa) (41) and Ladino clo­ This technical bulletin summa­ ver (T?'ifoUum ?·epens) (38). rizes and correlates 13 years of They are trifoliol (41, 160), research on coumestrol and re­ 4'-O-methylcoumestrol (42), me­ lated compounds in this labora­ dicagol (161), lucernol (205), tory as well as at other research sativol (205), 3'-methoxycoumes­ institutions throughout the world. trol (45), and 1l,12-dimethoxy­ It aiso includes some of the stud­ 7 -hydroxycoumestan (206). This ies on othe'l' forage estrogens as type of compound has also been they relate to coumestrol. Analytical Procedures An early method of determin­ estrogenic activity has been mea­ ing estrogenic activity in plant sured by the increase in uterine material was the Allen-Doisy test weight of ovariectomized or im­ (96), which is based on a deter­ mature female mice or rats (49, mination of the onset of estrus in 56, 83, 197). Once the estro'genic the test animal by the appear­ ance of cornified epithelial cells compound is identified, chromato­ in vaginal smears~ In most of the graphic methods (156) can often work on the isolation of estro­ be used for its quantitative deter­ genic constituents from forages, mination.
Recommended publications
  • Coumestrol and Genistein
    DISSOCIATION OF UTEROTROPHIC ACTION FROM IMPLANTATION-INDUCING ACTIVITY IN TWO NON-STEROIDAL OESTROGENS (COUMESTROL AND GENISTEIN) E. PEREL and H. R. LINDNER Department of Biodynamics, Weizmann Institute of Science, Rehovot, Israel (Received 19th June 1969) Summary. The phyto-oestrogens coumestrol (7,12-dihydroxycoume- stan) and genistein (5,7,4'-trihydroxyisoflavone) induced uterine growth in ovariectomized rats, but failed to induce ovum implantation in mated ovariectomized, gestagen-maintained rats and in intact lactating rats when given at dose levels effective in uterine weight assays. Oestradiol- 17ß, under similar conditions, induced ovum implantation even at dose levels below those required for a uterine weight response. Diethyl- stilboestrol and large doses of oestradiol- 17a (5 to 10 pg) were effective in both assays. It is suggested that different uterine receptors may be involved in mediating the uterine-growth-promoting and implantation- inducing actions of oestrogen. The phyto-oestrogens coumestrol (7,12-dihydroxycoumestan) and genistein (5,7,4'-trihydroxyisoflavone) are able to mimic some of the actions of steroidal oestrogens, e.g. to stimulate uterine growth in ovariectomized mice (Bickoff, Booth, Lyman, Livingston, Thompson & DeEds, 1957; Wong & Flux, 1962) and sheep (Braden, Hart & Lamberton, 1967; Lindner, 1967; Shutt, Braden & Lindner, 1969). Another characteristic action of steroidal oestrogens is their ability to induce implantation of the dormant blastocyst in the ovariectomized, progesterone-maintained rat (Krehbiel, 1941; Canivenc & Laffargue, 1956; Shelesnyak, 1959; Mayer & Meunier, 1959; Psychoyos, 1961; Nutting & Meyer, 1963). We wished to examine whether the latter response could also be elicited, or modified, by non-steroidal oestrogens. Three-month-old Wistar-derived rats (with a body weight of 207 g ± 1 -5 S.E.) were fed unrestricted Purina Laboratory Chow (Ralston Purina Co., St.
    [Show full text]
  • Glossary Terms
    Glossary Terms € 1584 5W6 5501 a 7181, 12203 5’UTR 8126 a-g Transformation 6938 6Q1 5500 r 7181 6W1 5501 b 7181 a 12202 b-b Transformation 6938 A 12202 d 7181 AAV 10815 Z 1584 Abandoned mines 6646 c 5499 Abiotic factor 148 f 5499 Abiotic 10139, 11375 f,b 5499 Abiotic stress 1, 10732 f,i, 5499 Ablation 2761 m 5499 ABR 1145 th 5499 Abscisic acid 9145 th,Carnot 5499 Absolute humidity 893 th,Otto 5499 Absorbed dose 3022, 4905, 8387, 8448, 8559, 11026 v 5499 Absorber 2349 Ф 12203 Absorber tube 9562 g 5499 Absorption, a(l) 8952 gb 5499 Absorption coefficient 309 abs lmax 5174 Absorption 309, 4774, 10139, 12293 em lmax 5174 Absorptivity or absorptance (a) 9449 μ1, First molecular weight moment 4617 Abstract community 3278 o 12203 Abuse 6098 ’ 5500 AC motor 11523 F 5174 AC 9432 Fem 5174 ACC 6449, 6951 r 12203 Acceleration method 9851 ra,i 5500 Acceptable limit 3515 s 12203 Access time 1854 t 5500 Accessible ecosystem 10796 y 12203 Accident 3515 1Q2 5500 Acclimation 3253, 7229 1W2 5501 Acclimatization 10732 2W3 5501 Accretion 2761 3 Phase boundary 8328 Accumulation 2761 3D Pose estimation 10590 Acetosyringone 2583 3Dpol 8126 Acid deposition 167 3W4 5501 Acid drainage 6665 3’UTR 8126 Acid neutralizing capacity (ANC) 167 4W5 5501 Acid (rock or mine) drainage 6646 12316 Glossary Terms Acidity constant 11912 Adverse effect 3620 Acidophile 6646 Adverse health effect 206 Acoustic power level (LW) 12275 AEM 372 ACPE 8123 AER 1426, 8112 Acquired immunodeficiency syndrome (AIDS) 4997, Aerobic 10139 11129 Aerodynamic diameter 167, 206 ACS 4957 Aerodynamic
    [Show full text]
  • Changes of Phytoestrogens Daidzein, Genistein and Their Glycosides Daidzin and Genistin and Coumestrol During Processing of Soyabeans
    Czech J. Food Sci. Vol. 22, Special Issue Changes of Phytoestrogens Daidzein, Genistein and Their Glycosides Daidzin and Genistin and Coumestrol during Processing of Soyabeans J. LOJZA*, V. SCHULZOVÁ and J. HAJŠLOVÁ Department of Food Chemistry and Analysis, Institute of Chemical Technology, Prague, Czech Republic, *E-mail: [email protected] Abstract: Phytoestrogens represent biologically active compounds showing estrogenic activity similar to that of sex hormones – estrogens. Various adverse effects such as sterility, increase of females’ genitals, lost of males’ copulation activity, etc. were observed in farm animals after exposure to higher amounts of fodder containing phytoestrogens. On the other side, their presence in human diet is nowadays the object of many research stud- ies concerned with prevention of breast and prostate cancer, osteoporosis and other hormone-linked diseases by dietary intake of phytoestrogens. Soya (Glycine max) is one of the main sources of these compounds in diet. Isoflavones daidzein and genistein occurring either free or bound in glycosides are the main phytoestrogens in this food crop. Coumesterol representing coumestans is another effective phytoestrogen contained in some ed- dible plants. In the first part of our study, analytical method for determination of free and total phytoestrogens was developed and validated. Following steps are included: (i) acid hydrolysis (only for “total phytoestrogens” analysis), (ii) extraction with methanol/water mixture, (iii) SPE preconcentration; (iv) identification/quantifica- tion using HPLC/DAD/FLD. The aim of present study was to document the fate of phytoestrogens and their forms during household/industrial processing. As documented in our experiments the most dynamic changes of phytoestrogen levels occur during soyabeans sprouting.
    [Show full text]
  • Ginsenoside Rh1 Induces MCF-7 Cell Apoptosis and Autophagic Cell Death Through ROS-Mediated Akt Signaling
    cancers Article Ginsenoside Rh1 Induces MCF-7 Cell Apoptosis and Autophagic Cell Death through ROS-Mediated Akt Signaling Diem Thi Ngoc Huynh 1,2, Yujin Jin 1, Chang-Seon Myung 1 and Kyung-Sun Heo 1,* 1 College of Pharmacy, Chungnam National University, Daejeon 34134, Korea; [email protected] (D.T.N.H.); [email protected] (Y.J.); [email protected] (C.-S.M.) 2 Department of Pharmacy, Da Nang University of Medical Technology and Pharmacy, Da Nang 550000, Vietnam * Correspondence: [email protected]; Tel.: +82-42-821-5927 Simple Summary: Breast cancer (BC) is the most common cause of cancer-related deaths among women worldwide, and its incidence has been increasing. However, current therapeutic approaches, such as chemotherapy, radiation, and hormonal therapy, have become increasingly ineffective because of their severe adverse effects and multidrug resistance. Therefore, the discovery of new potential candidates for BC therapy is essential. Here, we investigated whether ginsenoside Rh1 exhibits anticancer effects on BC. We found that this ginsenoside effectively inhibited the growth of BC cells in both cell cultures and mice. Therefore, ginsenoside Rh1 is a promising candidate for BC treatment. Abstract: Breast cancer (BC) is the leading cause of cancer-related deaths among women worldwide. Ginsenosides exhibit anticancer activity against various cancer cells. However, the effects of gin- senoside Rh1 on BC and the underlying mechanisms remain unknown. Here, we investigated the anticancer effects of Rh1 on human BC MCF-7 and HCC1428 cells and the underlying signaling pathways. The anticancer effects of Rh1 in vitro were evaluated using sulforhodamine B (SRB), Citation: Huynh, D.T.N.; Jin, Y.; 3-(4, 5-dimethylthiazole-2-yl)-2, 5-diphenyltetrazolium bromide (MTT), clonogenic assay, propidium Myung, C.-S.; Heo, K.-S.
    [Show full text]
  • Wedelolactone Induces Growth of Breast Cancer Cells by Stimulation of Estrogen Receptor Signalling
    Journal of Steroid Biochemistry & Molecular Biology 152 (2015) 76–83 Contents lists available at ScienceDirect Journal of Steroid Biochemistry & Molecular Biology journa l homepage: www.elsevier.com/locate/jsbmb Wedelolactone induces growth of breast cancer cells by stimulation of estrogen receptor signalling a a,b c,d c,d a,d, Tereza Nehybova , Jan Smarda , Lukas Daniel , Jan Brezovsky , Petr Benes * a Laboratory of Cellular Differentiation, Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5/A36, 625 00 Brno, Czech Republic b Masaryk Memorial Cancer Institute, RECAMO, Zluty kopec 7, 656 53 Brno, Czech Republic c Loschmidt Laboratories, Department of Experimental Biology and Research Centre for Toxic Compounds in the Environment RECETOX, Faculty of Science, Masaryk University, Kamenice 5/A13, 625 00 Brno, Czech Republic d International Clinical Research Center, Center for Biological and Cellular Engineering, St. Anne’s University Hospital, Pekarska 53, 656 91 Brno, Czech Republic A R T I C L E I N F O A B S T R A C T Article history: Wedelolactone, a plant coumestan, was shown to act as anti-cancer agent for breast and prostate Received 17 December 2014 carcinomas in vitro and in vivo targeting multiple cellular proteins including androgen receptors, Received in revised form 9 April 2015 5-lipoxygenase and topoisomerase IIa. It is cytotoxic to breast, prostate, pituitary and myeloma cancer Accepted 26 April 2015 cell lines in vitro at mM concentrations. In this study, however, a novel biological activity of nM dose of Available online 28 April 2015 wedelolactone was demonstrated. Wedelolactone acts as agonist of estrogen receptors (ER) a and b as demonstrated by transactivation of estrogen response element (ERE) in cells transiently expressing either Keywords: ERa or ERb and by molecular docking of this coumestan into ligand binding pocket of both ERa and ERb.
    [Show full text]
  • Coumestrol Suppresses Proliferation of ES2 Human Epithelial Ovarian Cancer Cells
    W LIM, W JEONG and others Coumestrol inhibits progression 228:3 149–160 Research of EOC Coumestrol suppresses proliferation of ES2 human epithelial ovarian cancer cells Whasun Lim1,*, Wooyoung Jeong2,* and Gwonhwa Song1 1Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 136-713, Correspondence Republic of Korea should be addressed 2Department of Animal Resources Science, Dankook University, Cheonan 330-714, to G Song Republic of Korea Email *(W Lim and W Jeong contributed equally to this work) [email protected] Abstract Coumestrol, which is predominantly found in soybean products as a phytoestrogen, Key Words has cancer preventive activities in estrogen-responsive carcinomas. However, effects and " ovary molecular targets of coumestrol have not been reported for epithelial ovarian cancer (EOC). " reproduction In the present study, we demonstrated that coumestrol inhibited viability and invasion and " reproductive tract induced apoptosis of ES2 (clear cell-/serous carcinoma origin) cells. In addition, immuno- " coumestrol reactive PCNA and ERBB2, markers of proliferation of ovarian carcinoma, were attenuated in " clear cell carcinoma their expression in coumestrol-induced death of ES2 cells. Phosphorylation of AKT, p70S6K, ERK1/2, JNK1/2, and p90RSK was inactivated by coumestrol treatment in a dose- and time- dependent manner as determined in western blot analyses. Moreover, PI3K inhibitors Journal of Endocrinology enhanced effects of coumestrol to decrease phosphorylation of AKT, p70S6K, S6, and ERK1/2. Furthermore, coumestrol has strong cancer preventive effects as compared to other conventional chemotherapeutics on proliferation of ES2 cells. In conclusion, coumestrol exerts chemotherapeutic effects via PI3K and ERK1/2 MAPK pathways and is a potentially novel treatment regimen with enhanced chemoprevention activities against progression of EOC.
    [Show full text]
  • 10/12/2019 Herbal Preparations with Phytoestrogens- Overview of The
    Herbal preparations with phytoestrogens- overview of the adverse drug reactions Introduction For women suffering from menopausal symptoms, treatment is available if the symptoms are particularly troublesome. The main treatment for menopausal symptoms is hormone replacement therapy (HRT), although other treatments are also available for some of the symptoms (1). In recent years, the percentage of women taking hormone replacement therapy has dropped (2, 3). Many women with menopausal symptoms choose to use dietary supplements on a plant-based basis, probably because they consider these preparations to be "safe" (4). In addition to product for relief of menopausal symptoms, there are also preparations on the market that claim to firm and grow the breasts by stimulating the glandular tissue in the breasts (5). All these products contain substances with an estrogenic activity, also called phytoestrogens. These substances are found in a variety of plants (4). In addition, also various multivitamin preparations are on the market that, beside the vitamins and minerals, also contain isoflavonoids. Because those are mostly not specified and present in small quantities and no estrogenic effect is to be expected, they are not included in this overview. In 2015 and 2017 the Netherlands Pharmacovigilance Centre Lareb informed the Netherlands Food and Consumer Product Safety Authority (NVWA) about the received reports of Post-Menopausal Vaginal Hemorrhage Related to the Use of a Hop-Containing Phytotherapeutic Products MenoCool® and Menohop® (6, 7). Reports From September 1999 until November 2019 the Netherlands Pharmacovigilance Centre Lareb received 51 reports of the use of phytoestrogen containing preparations (see Appendix 1). The reports concern products with various herbs to which an estrogenic effect is attributed.
    [Show full text]
  • Glossary of Terms
    Glossary of Terms Acceptable Daily Intake or Allowed Daily Intake (ADI) → Dose- Response Relationship/Curve Allergen The allergen is a material which triggers an allergic reaction. Allopathy The term allopathy was created by Christian Friedrich Samuel Hahnemann (1755– 1843) (from the Greek prefix άλλος, állos, “other”, “different” and the suffix πάϑος, páthos, “suffering”) in order to distinguish his technique (homeopathy) from the traditional medicine of his age. Today, allopathy means a medicine based on the principles of modern pharmacology. Anaphylactic shock Anaphylaxis (or an anaphylactic shock) is a whole-body, rapidly developing aller- gic reaction, which may lead to lethal respiratory and circulatory failure. Antibody Antibodies are proteins produced by the immune system to neutralize exogenous (external) substances. Chromatography, chromatogram Chromatography is the common name of different techniques used to separate mix- tures of compounds. HPLC stands for high-performance liquid chromatography. A chromatogram is the pattern of separated substances obtained by chromatography. Colloidal sol A colloidal sol is a suspension of very small solid particles in a continuous liquid medium. Colloidal sols are quite stable and show the Tyndall effect (light scatter- ing by particles in a colloid). They can be quite stable. Examples include blood, pigmented ink, and paint. Colloidal sols can change their viscosity quickly if they © Springer International Publishing Switzerland 2014 311 L. Kovács et al., 100 Chemical Myths, DOI 10.1007/978-3-319-08419-0 312 Glossary of Terms are thixotropic. Examples include quicksand and paint, both of which become more fluid under pressure. Concentrations: parts per notations In British/American practice, the parts-per notation is a set of pseudo-units to de- scribe concentrations smaller than thousandths: 1 ppm (parts per million, 10−6 parts) One out of 1 million, e.g.
    [Show full text]
  • The Concise Guide to PHARMACOLOGY 2015/16
    Edinburgh Research Explorer The Concise Guide to PHARMACOLOGY 2015/16 Citation for published version: Alexander, SP, Fabbro, D, Kelly, E, Marrion, N, Peters, JA, Benson, HE, Faccenda, E, Pawson, AJ, Sharman, JL, Southan, C, Davies, JA & Collaborators, C 2015, 'The Concise Guide to PHARMACOLOGY 2015/16: Enzymes', British Journal of Pharmacology, vol. 172, no. 24, pp. 6024-6109. https://doi.org/10.1111/bph.13354 Digital Object Identifier (DOI): 10.1111/bph.13354 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: British Journal of Pharmacology General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 05. Oct. 2021 S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2015/16: Enzymes. British Journal of Pharmacology (2015) 172, 6024–6109 THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: Enzymes Stephen PH Alexander1, Doriano Fabbro2, Eamonn
    [Show full text]
  • A New Coumestan Glucoside from Eclipta Prostrata
    Natural Product Sciences 26(4) : 289-294 (2020) https://doi.org/10.20307/nps.2020.26.4.289 A New Coumestan Glucoside from Eclipta prostrata Young Ju Seo†, Hyun Woo Kil†, Taewoong Rho, and Kee Dong Yoon* College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon-si, Gyeonggi-do 14662, Korea Abstract Eclipta prostrata is an annual herb, belonging to Asteraceae family, and has been traditionally used to improve immunity and treat hepatitis and bacterial disease in Korea. In this study, a new coumestan glucoside (1) along with ten known compounds (2 – 11) was isolated from E. prostrata. The chemical structures of isolates were elucidated to be wedelolactone-9-O--D-glucopyranoside (1), wedelolactone (2), demethylwedelolactone (3), apigenin (4), apigenin-7-sulfate (5), luteolin (6), luteolin-7-sulfate (7), luteolin-7-O--D-glucopyranoside (8), pratensein-7-O--D-glucopyranoside (9), 3,4-di-O-caffeoylquinic acid (10) and 3,5-di-O-caffeoylquinic acid (11) based on the spectroscopic evidence. Keywords Eclipta prostrata, Asteraceae, Phenolic compounds, Wedelolactone-9-O--D-glucopyranoside Introduction infrared spectroscopy (FT-IR). Eclipta prostrata is an annual herb, belonging to Experimental Asteracea family, and distributed in the tropical and subtropical areas, especially Asia and Africa.1 Eclipta General experimental procedures – The preparative prostrata has been traditionally used to improve immunity HPLC was performed using a Gilson HPLC system and treat hepatitis and bacterial diseases in Korea.2 In (Middleton, WI, USA) composed of a binary pump, a India, E. prostrata has been used to treat body pain, fever, liquid handler, and a UV/Vis detector with a Luna C18(2) hair loss, jaundice, liver enlargement and skin diseases.3 (21.2 × 250 mm I.D., 5 μm, Phenomenex, Torrance, CA, Recent biological evidence revealed that the E.
    [Show full text]
  • Tyrosinase Inhibitors from Traditional Chinese Medicine As Potential Anti-Hyperpigmentation Agents
    Tyrosinase Inhibitors from Traditional Chinese Medicine as Potential Anti-hyperpigmentation agents Author Shi, Gengxuan Published 2019 Thesis Type Thesis (Masters) School School of Environment and Sc DOI https://doi.org/10.25904/1912/1780 Copyright Statement The author owns the copyright in this thesis, unless stated otherwise. Downloaded from http://hdl.handle.net/10072/387690 Griffith Research Online https://research-repository.griffith.edu.au Tyrosinase Inhibitors from Traditional Chinese Medicine as Potential Anti-hyperpigmentation agents Gengxuan SHI School of Environment and Science Griffith Science Griffith University Submitted in fulfilment of the requirements of the degree of Master of Science July 2019 i Abstract Several treatments for skin pigmentation are available today, however, many have unwanted side effects. Classic drugs like hydroquinone, arbutin, mequinol and kojic acid have been considered strongly carcinogenic, with related adverse effects. Traditional Chinese medicines (TCMs) have long been documented for their skin- lightening properties with little known negative effects. However, little is known about precisely how these herbal medicines work and what are the chemical basis for their activity. In this project, a 96-well plate based tyrosinase assay was established and used to test 44 TCM with known skin-lightening properties. Out of 44, 17 TCM extracts showed over 60% inhibition against tyrosinase at the concentration of 0.5 mg/mL. One of the TCM extracts, Xanthium strumarium L. extract, possessed 81.7% inhibition at 0.5 mg/mL. Further bioassay-guided isolation of the crude extract resulted in 10 compounds. Three of the compounds showed moderate activity against tyrosinase with IC50 values of 0.18 mM (cytidine), 0.29 mM (1,4-dicaffeoylquinic acid) and 2.47 mM (xanthiside).
    [Show full text]
  • This Article Was Originally Published in Hormones, Brain and Behavior 2Nd
    This article was originally published in Hormones, Brain and Behavior 2nd edition, published by Elsevier, and the attached copy is provided by Elsevier for the author's benefit and for the benefit of the author's institution, for non- commercial research and educational use including without limitation use in instruction at your institution, sending it to specific colleagues who you know, and providing a copy to your institution’s administrator. All other uses, reproduction and distribution, including without limitation commercial reprints, selling or licensing copies or access, or posting on open internet sites, your personal or institution’s website or repository, are prohibited. For exceptions, permission may be sought for such use through Elsevier's permissions site at: http://www.elsevier.com/locate/permissionusematerial Gore A C and Crews D Environmental Endocrine Disruption of Brain and Behavior. In: Donald W. Pfaff, Arthur P. Arnold, Anne M. Etgen, Susan E. Fahrbach and Robert T. Rubin, editors. Hormones, Brain and Behavior, 2nd edition, Vol 3. San Diego: Academic Press; 2009. pp. 1789-1816. Author's personal copy 56 Environmental Endocrine Disruption of Brain and Behavior A C Gore and D Crews, University of Texas at Austin, Austin, TX, USA ß 2009 Elsevier Inc. All rights reserved. Chapter Outline 56.1 Introduction to Endocrine Disruption 1790 56.1.1 Critical Issues about Endocrine Disruption 1791 56.1.1.1 Life stage and timing 1791 56.1.1.2 Latency of effects 1791 56.1.1.3 Sensitivity to EDCs 1792 56.1.1.4 Degradation and metabolism,
    [Show full text]